Nalaganje...
Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke
Metformin is currently the first-line treatment drug for type 2 diabetes. Metformin is a well-known activator of AMP-activated protein kinase (AMPK). In experimental studies, metformin has been shown to exert direct vascular effects by increasing vascular endothelial growth factor expression and imp...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4061245/ https://ncbi.nlm.nih.gov/pubmed/24649970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejn.12556 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|